Research paper
Reversion of multidrug resistance using nanoparticles in vitro: Influence of the nature of the polymer

https://doi.org/10.1016/0378-5173(96)04559-0Get rights and content

Abstract

Previous studies have already shown that polyalkylcyanoacrylate nanoparticles were able to overcome multidrug resistance in vitro. The study described in this paper investigated other types of nanoparticles, made of poly (lactic acid) PLA, poly (lactic-co-glycolic acid) PLGA and alginate, in order to determine if overcoming of resistance could be achieved with any nanoparticles independently of the nature of the polymer. In a first step, PLA and PLGA nanoparticles loaded with doxorubicin have been formulated, and the cytotoxicity of each preparation has been evaluated against P388 sensitive and resistant cells. Only polyalkylcyanoacrylate nanoparticles were effective: doxorubicin release experiments allowed to incriminate too rapid doxorubicin release in the case of PLA, PLGA and alginate nanoparticles to explain their lack of efficacy to overcome MDR.

References (20)

There are more references available in the full text version of this article.

Cited by (72)

  • Targeting strategies using PLGA nanoparticles for efficient drug delivery

    2023, Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for Drug Delivery
  • Methods for nanoencapsulation

    2023, Green Sustainable Process for Chemical and Environmental Engineering and Science: Recent Advances in Nanocarriers
  • Conclusion and Future Prospective of Polymeric Nanoparticles for Cancer Therapy

    2019, Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics
  • Mechanism for the Nano-Based Drug Delivery System

    2018, Characterization and Biology of Nanomaterials for Drug Delivery: Nanoscience and Nanotechnology in Drug Delivery
  • Synergistic effects of negative-charged nanoparticles assisted by ultrasound on the reversal multidrug resistance phenotype in breast cancer cells

    2017, Ultrasonics Sonochemistry
    Citation Excerpt :

    Recent decades have witnessed several attempts to explore positive-charged nanoparticles (NPs) based strategies to overcome MDR [3]. For example, positive-charged Pluronic nanoparticles can participate in the enhancement of drug cytotoxicity [4,5]; the addition of resistance modulators or surfactants to PACA nanocarrier with positive charge increases intracellular drug concentration thereby reversing MDR [6]. Since cell surface is negative, positive charged NPs easily enter into cells resulting in efficient cellular uptake.

  • Overcoming cellular multidrug resistance using classical nanomedicine formulations

    2012, European Journal of Pharmaceutical Sciences
    Citation Excerpt :

    Nanomedicines do not cross the cellular membrane in ‘free’ form, but are incorporated into endocytotic vesicles, thereby preventing them from being recognized by efflux pumps. Upon this shuttling across the cellular membrane, nanomedicines and/or the drug molecules released from them during endo-lysosomal trafficking, are delivered deeply into (cancer) cells, and thereby are able, at least to some extent, to bypass Pgp- and MRP-mediated efflux mechanisms (Thierry et al., 1992; Cuvier et al., 1992; Nemati et al., 1996; de Verdiare et al., 1997; Minko et al., 1998, 1999; Goren et al., 2000; Mayer and Shabbits, 2001; Mamot et al., 2003; Duncan, 2006; Sahay et al., 2010). Many studies that aimed to assess the ability of nanomedicines to overcome multidrug resistance, however, are based on the use of semi-artificial in vitro models, i.e. on cells transfected with plasmid DNA encoding for Pgp and/or MRP.

View all citing articles on Scopus
View full text